The San Francisco-based software firm paid US$26 million in cash for the company, and could issue up to US$37 million more in equity. The deal closed late last month. (The Logic)

Talking point: Founded in 2020, Pathway offered a chatbot that doctors could ask questions about treatment and drug dosage, powered by its own large language model (LLM) trained on papers from medical journals. Pre-acquisition, the startup had raised US$6.3 million in venture funding, per PitchBook data, from backers including Desjardins Capital, Panache Ventures and the founders of Canadian medtech firms Figure1 and Dialogue. Doximity, which makes an app that doctors can use for virtual appointments, will now build Pathway’s LLM into its products. All six Pathway staff will join Doximity, which doesn’t currently plan to expand in Montreal, said spokesperson Amanda Cox.